Navigation Links
Spaulding Clinical Honored at BizTech Conference
Date:5/19/2011

WEST BEND, Wis., May 19, 2011 /PRNewswire/ -- Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, LLC proudly receives the 2011 IQ (Innovation Quotient) award sponsored by the Marquette University's Graduate School of Management and BizTimes Media, a magazine dedicated to providing Wisconsin business leaders news, analysis and strategic insights. The revolutionary Spaulding IQ(SM) electrocardiogram was recognized with nine other award winners for innovative, clever, and unique products, services, or processes.

The Spaulding IQ is a revolutionary 12-lead electrocardiographic machine, about the size of a hockey puck, which instead of keyboards and LCD displays, utilizes a microphone and voice-print biometrics to identify the patient.  IQ is capable of recording five minutes of data versus the standard 10 seconds of traditional ECG devices.  The Spaulding IQ was designed to be a cost-effective solution for pharmaceutical clients that have not centralized ECG drug trial information due to cost and complexity.  The device is part of a total ECG Solution, from Spaulding Clinical, for clinical trials where cardiac safety data is required.

Randol Spaulding, CEO and founder of Spaulding Clinical, commented, "It is difficult to put into words how proud I am of the teamwork and effort it has taken to move the Spaulding IQ product from vision through approval.  It is a great achievement and only fitting that we, the makers of IQ, win the IQ Award.  We are honored to be recognized by Marquette and BizTimes Media."  

Spaulding Clinical will be demonstrating the cutting edge "Spaulding IQ" ECG device and Core ECG Lab Solutions from June 19 – 22, 2011 in booth 1905 at the DIA (Drug Information Association) meeting in Chicago, IL. To learn more about how Spaulding can assist with your Clinical Pharmacology programs, Pharmacokinetic analysis, or ECG Core lab programs, please contact us at SpauldingPK@spauldingclinical.com or 262-306-3331.  

About Spaulding Clinical

Spaulding Clinical Research, LLC (www.spauldingclinical.com) is a Clinical Pharmacology Research Unit and Cardiac Core Lab that offers a full range of global services from study design through study execution/conduct, data management, statistical analysis, and clinical summary/expert reporting.  Spaulding has extensive experience conducting TQT, first-in-human, multiple rising dose, bioavailability/bioequivalence, drug interaction, and food effect studies. As a Phase 1-4 Core Lab provider, Spaulding offers the complete suite of equipment provisioning and electrocardiogram over-reading services with state-of-the-art technologies and expertly trained cardiologists.


'/>"/>
SOURCE Spaulding Clinical Research, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spaulding Clinical Welcomes Dr. Aziz Karim, Clinical Pharmacokinetic Consultant
2. Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA
3. Omeros Announces Clinical Development Programs for OMS103HP and OMS302
4. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
5. Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
6. Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting
7. Dendreon Announces Presentation of PROVENGE Data at the 2011 American Society of Clinical Oncology Annual Meeting
8. ARX-01 and ARX-03 Clinical Results Presented at the 30th Annual Scientific Meeting of the American Pain Society
9. Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians
10. Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting
11. PLC Medical Systems Adds Vice President of Clinical Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/10/2017)... COLUMBIA, S.C. , July 10, 2017 /PRNewswire/ ... product purchasing and patient support services organization serving ... announced today the launch of four significant, value-added ... into market insights, better manage reimbursement and improve ... Ig and factor therapies. ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... Sharon Kleyne is proud of the ... research center at Bio-Logic Aqua Research® Water Life Science®, has been released in ... sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to eliminating ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing ... by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the ... 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower ...
Breaking Medicine News(10 mins):